Skip to main content

People in the News: Rhonda Rhyne, Perry Fell, Conrad Mir

Premium

Proteomics-based diagnostics developer Prevencio has appointed H. Perry Fell to be chairman of the board and Rhonda Rhyne to be president, CEO, and board director.

Fell formerly was chairman and CEO of NanoString Technologies and he co-founded Seattle Genetics. Rhyne has been president of CardioDynamics, and she founded the consulting company Rhyne Life Sciences.


Pressure BioSciences said this week that Chief Financial Officer Conrad Mir has resigned from his post, effective immediately. He has been named CEO of Competitive Technologies (CTI), a biotech firm that distributes a pain therapy medical device, CTI said separately this week.

Pressure Bio has named Richard Thomley to serve as the firm's acting CFO. Thomley has been an independent financial consultant to the company since March.

The Scan

Gap in COVAX Doses

BBC News reports that COVAX is experiencing a vaccine shortfall, as the Serum Institute of India has paused exports.

Sanofi, GSK Report Promising Results

The Wall Street Journal reports that the candidate SARS-CoV-2 vaccine from Sanofi and GlaxoSmithKline has had encouraging early results.

Influence of Luck

The New York Times examines how the US avoided variant-fueled increases in COVID-19 cases.

PLOS Papers on Retina GWAS, Hantaan Virus, COVID-19 Phenome-Wide Association Study

In PLOS this week: genome-wide association study of retinal morphology, analysis of hantaan virus found in a mouse, and more.